Adequate plasma levels of dolutegravir in combination with ritonavir-boosted darunavir: a pharmacokinetic subgroup analysis of the DUALIS study.

J Antimicrob Chemother 2020 Jul 7. Epub 2020 Jul 7.

Technical University of Munich, School of Medicine, University Hospital rechts der Isar, Department of Medicine II, Ismaninger Str. 22, 81675 Munich, Germany.

Download full-text PDF

Source
http://dx.doi.org/10.1093/jac/dkaa234DOI Listing
July 2020

Publication Analysis

Top Keywords

combination ritonavir-boosted
4
dolutegravir combination
4
subgroup analysis
4
ritonavir-boosted darunavir
4
darunavir pharmacokinetic
4
pharmacokinetic subgroup
4
analysis dualis
4
dualis study
4
adequate plasma
4
levels dolutegravir
4
plasma levels
4
dualis
1
analysis
1
study
1
darunavir
1
dolutegravir
1
levels
1
combination
1
ritonavir-boosted
1
pharmacokinetic
1

References

(Supplied by CrossRef)
Efficacy and safety of switching to dolutegravir/lamivudine fixed-dose two-drug regimen versus continuing a tenofovir alafenamide-based three- or four-drug regimen for maintenance of virologic suppression in adults with HIV-1: phase 3, randomized, non-inferiority TANGO study
van Wyk et al.
Clin Infect Dis 2020

Similar Publications